Beata Zamlynny

Structural basis for selectivity and diversity in angiotensin II receptors

Haitao Zhang, Gye Won Han, A. Batyuk et al. · Nature · 2017 · 216 citations · Full text

Medicine, Biochemistry, Pharmacology +14

Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation

Chuan Hong, Noel Byrne, Beata Zamlynny et al. · Nature Communications · 2021 · 119 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Disparity in IL-12 Release in Dendritic Cells and Macrophages in Response to <i>Mycobacterium tuberculosis</i> Is Due to Use of Distinct TLRs

Luca Pompei, Sihyug Jang, Beata Zamlynny et al. · The Journal of Immunology · 2007 · 104 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Discovery of Vibegron: A Potent and Selective β₃Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

Scott D. Edmondson, Cheng Zhu, Nam Fung Kar et al. · Journal of Medicinal Chemistry · 2015 · 102 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder

Jerry Di Salvo, Hiroshi Nagabukuro, L. Alexandra Wickham et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 59 citations

Medicine, Pharmacology, Pharmacotherapy +17